Menu
 
Research menu
Jump to menu

Publications:  Prof Yongjie Lu

Adams CD, Richmond R, Ferreira DLS, Spiller W, Tan V, Zheng J, Würtz P, Donovan J et al.(2019). Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiol Biomarkers Prev vol. 28, (1) 208-216.
10.1158/1055-9965.EPI-18-0079
Lin H-Y, Huang P-Y, Chen D-T, Tung H-Y, Sellers TA, Pow-Sang JM, Eeles R, Easton D et al.(2018). AA9int: SNP interaction pattern search using non-hierarchical additive model set. Bioinformatics vol. 34, (24) 4141-4150.
10.1093/bioinformatics/bty461
Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ, Kumar R, Allan JM et al.(2018). Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nature Communications vol. 9, (1)
10.1038/s41467-018-03178-z
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR et al.(2018). Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun vol. 9, (1)
10.1038/s41467-018-06863-1
Mancuso N, Gayther S, Gusev A, Zheng W, Penney KL, Kote-Jarai Z, Eeles R, Freedman M et al.(2018). Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. Nat Commun vol. 9, (1)
10.1038/s41467-018-06302-1
Adimonye A, Stankiewicz E, Touche SL, Kudahetti S, Tinwell B, Corbishley C, Lu Y-J, Watkin N et al.(2018). The Prognostic Value of PIK3CA Copy Number Gain in Penile Cancer. Urology
10.1016/j.urology.2018.03.056
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D et al.(2018). Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet vol. 50, (7) 928-936.
10.1038/s41588-018-0142-8
Adimonye A, Stankiewicz E, La-Touche S, Kudahetti S, Trevisan G, Tinwell B, Corbishley C, Lu Y-J et al.(2018). PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer. PLoS ONE vol. 13, (6) e0198905-e0198905.
10.1371/journal.pone.0198905
Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M et al.(2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nat Commun vol. 9, (1)
10.1038/s41467-018-04109-8
Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A et al.(2018). Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nat Genet vol. 50, (5) 682-692.
10.1038/s41588-018-0086-z
Adimonye A, Stankiewicz E, Kudahetti S, Trevisan G, Tinwell B, Corbishley C, Lu Y-J, Watkin N et al.(2018). Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway. Oncotarget vol. 9, (22) 16074-16086.
10.18632/oncotarget.24688
Aguirre-Hernández C, Maya-Pineda H, Millán JS, Man YKS, Lu Y-J, Halldén G(2018). Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy. Oncogenesis vol. 7, (1)
10.1038/s41389-017-0020-8
Sud A, Thomsen H, Law PJ, Försti A, Filho MIDS, Holroyd A, Broderick P, Orlando G et al.(2017). Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nature Communications vol. 8, (1)
10.1038/s41467-017-00320-1
Camacho N, Van Loo P, Edwards S, Kay JD, Matthews L, Haase K, Clark J, Dennis N et al.(2017). Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. PLoS Genet vol. 13, (9) e1007001-e1007001.
10.1371/journal.pgen.1007001
Stankiewicz E, Xueying M, Mangham DC, Xu L, Yeste-Velasco M, Fisher G, North B, Chaplin T et al.(2017). Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer. Scientific Reports Article 5124,
10.1038/s41598-017-05209-z
Xu L, Mao X, Guo T, Chan PY, Shaw G, Hines J, Stankiewicz E, Wang Y et al.(2017). The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis. Clin Cancer Res
10.1158/1078-0432.CCR-16-3081
Lin H-Y, Chen D-T, Huang P-Y, Liu Y-H, Ochoa A, Zabaleta J, Mercante DE, Fang Z et al.(2017). SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. Bioinformatics vol. 33, (6) 822-833.
10.1093/bioinformatics/btw762
Berney DM, Lu Y-J, Shamash J, Idrees M(2017). Postchemotherapy changes in testicular germ cell tumours: biology and morphology. Histopathology vol. 70, (1) 26-39.
10.1111/his.13078
Jiang H, Mao X, Huang X, Zhao J, Wang L, Xu J, Zhang H, Lu Y et al.(2016). Erratum to: TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer. Tumour Biol vol. 37, (10) 14331-14331.
10.1007/s13277-016-5132-9
Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB et al.(2016). Mutational signatures of ionizing radiation in second malignancies. Nature Communications vol. 7, Article 12605, 1-8.
10.1038/ncomms12605
Jiang H, Mao X, Huang X, Zhao J, Wang L, Xu J, Zhang H, Lu Y et al.(2016). TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer. Tumour Biol vol. 37, (9) 12397-12402.
10.1007/s13277-016-5116-9
Mao X, Luo F, Boyd LK, Zhou B, Zhang Y, Stankiewicz E, Marzec J, Vasiljevic N et al.(2016). NKAIN2 functions as a novel tumor suppressor in prostate cancer. Oncotarget
10.18632/oncotarget.11690
Wang Y, Shao N, Mao X, Zhu M, Fan W, Shen Z, Xiao R, Wang C et al.(2016). MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity. Oncotarget vol. 7, (30) 47444-47464.
10.18632/oncotarget.10165
Stankiewicz E, Mao X, Mangham DC, Xu L, Fisher G, North B, Moller H, Scardino P et al.(2016). Identification of FBXL4 as a bone metastasis-associated gene in prostate cancer. Scientific Reports vol. 7,
10.1158/1538-7445.AM2016-1614
Marzec J, Mao X, Li M, Wang M, Feng N, Gou X, Wang G, Sun Z et al.(2016). A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population. Oncotarget vol. 7, (16) 21393-21403.
10.18632/oncotarget.7250
Xu L, Mao X, Chan PY, Shamash J, Lu Y-J (2016). Analysis of prostate cancer circulating tumour cells isolated with a novel size-based system. LANCET. vol. 387, 25-25.
Imrali A, Mao X, Yeste-Velasco M, Shamash J, Lu Y(2016). Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin. Am J Cancer Res vol. 6, (8) 1772-1784.
Yeste-Velasco M, Linder ME, Lu Y-J(2015). Protein S-palmitoylation and cancer. Biochim Biophys Acta vol. 1856, (1) 107-120.
10.1016/j.bbcan.2015.06.004
Lian W-Q, Luo F, Song X-L, Lu Y-J, Zhao S-C(2015). Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies. Med Sci Monit vol. 21, 1902-1910.
10.12659/MSM.893579
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL et al.(2015). Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev vol. 24, (7) 1121-1129.
10.1158/1055-9965.EPI-14-0317
Coll-Bastus N, Mao X, Young BD, Sheer D, Lu Y-J(2015). DNA replication-dependent induction of gene proximity by androgen. Hum Mol Genet vol. 24, (4) 963-971.
10.1093/hmg/ddu508
Bao J-M, He M-Y, Liu Y-W, Lu Y-J, Hong Y-Q, Luo H-H, Ren Z-L, Zhao S-C et al.(2015). AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation. Am J Cancer Res vol. 5, (5) 1741-1750.
Zhang Y, Mao X-Y, Liu X, Song R-R, Berney D, Lu Y-J, Ren G(2015). High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer. Int J Clin Exp Med vol. 8, (9) 15127-15136.
Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, Cathcart P, Hines J et al.(2015). Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System. PLoS One vol. 10, (9)
10.1371/journal.pone.0138032
Zhao S-C, Zhou B-W, Luo F, Mao X, Lu Y-J(2015). The structure and function of NKAIN2-a candidate tumor suppressor. Int J Clin Exp Med vol. 8, (10) 17072-17079.
Ren G, Zhang Y, Mao X, Liu X, Mercer E, Marzec J, Ding D, Jiao Y et al.(2014). Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?. OMICS vol. 18, (10) 615-624.
10.1089/omi.2014.0042
Mercer EJ, Imrali A, Sharpe K, Hallden G, Lu Y-J (2014). Utilizing a potent and selective nonreplicating adenoviral mutant (Ad5-TV-CU), with gene expression controlled by androgen receptor-dependent activation domains in the TMPRSS2 gene, as a novel prodrug-converting enzyme therapy for prostate cancer. CANCER RESEARCH. vol. 74,
10.1158/1538-7445.AM2014-713
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljevi¿ N, Chaplin T et al.(2014). Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol vol. 232, (5) 566-577.
10.1002/path.4327
Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M et al.(2014). Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res vol. 74, (3) 896-907.
10.1158/0008-5472.CAN-13-1702
Pantazi E, Gemenetzidis E, Trigiante G, Warnes G, Shan L, Mao X, Ikram M, Teh MT et al. (2014). GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis. Cell Death and Disease. vol. 5,
10.1038/cddis.2013.535
Pantazi E, Gemenetzidis E, Trigiante G, Warnes G, Shan L, Mao X, Ikram M, Teh M-T et al.(2014). GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis. Cell Death Dis vol. 5,
10.1038/cddis.2013.535
Zhang H, Fan Y, Ge N, Wang X, Sun W, Mao R, Bu W, Creighton CJ et al.(2014). Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. Journal of Pathology vol. 232, (1) 75-86.
10.1002/path.4283
Zhao C-B, Bao J-M, Lu Y-J, Zhao T, Zhou X-H, Zheng D-Y, Zhao S-C(2014). Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer. Am J Cancer Res vol. 4, (4) 369-377.
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljevíc N, Chaplin T et al.(2014). Erratum:Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014); 232: 566-577)). Journal of Pathology vol. 234, (1)
10.1002/path.4396
Pantazi E, Gemenetzidis E, Trigiante G, Warnes G, Shan L, Mao X, Ikram M, Teh MT et al. (2014). GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis. Cell death & disease. vol. 5,
10.1038/cddis.2013.535
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Marzec J, Vasiljevic N, Chaplin T, Foster JM et al.(2014). Identification of ZDHHC14 as a novel human tumour suppressor: gene. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34, S90-S90.
Mao X, Li J, Xu X, Boyd LK, He W, Stankiewicz E, Kudahetti SC, Cao G et al.(2014). Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer. Am J Cancer Res vol. 4, (6) 886-896.
Bastus NC, Mao X, Young BD, Sheer D, Lu Y-J(2014). Novel function of androgen receptor-the regulation of DNA replication and genomic movement. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34, S89-S89.
Mao X, Marzec J, Li M, Zhang Z, Feng N, Gou X, Sun Z, Xu J et al.(2014). Population differences in the genetic risk of prostate cancer and predisposition loci in the Chinese population. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34, S89-S89.
Xu L, Irrami A, Shamash J, Lu Y-J(2014). Size-based isolation of circulating tumour cells and its application in advanced prostate cancer. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34, S89-S89.
Sharpe K, Stewart GD, Mackay A, Van Neste C, Rofe C, Berney D, Kayani I, Bex A et al.(2013). The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. Clin Cancer Res vol. 19, (24) 6924-6934.
10.1158/1078-0432.CCR-13-1631
Vasiljevi¿ N, Ahmad AS, Beesley C, Thorat MA, Fisher G, Berney DM, Møller H, Yu Y et al.(2013). Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer. Prostate Cancer Prostatic Dis vol. 16, (1) 35-40.
10.1038/pcan.2012.47
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G et al.(2013). A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. HUMAN MOLECULAR GENETICS vol. 22, (2) 408-415.
10.1093/hmg/dds425
Li J, Mercer E, Gou X, Lu Y-J(2013). Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res vol. 3, (2) 127-151.
Ren G, Liu X, Mao X, Zhang Y, Stankiewicz E, Hylands L, Song R, Berney DM et al.(2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancer. Genes Chromosomes and Cancer vol. 51, (11) 1014-1023.
10.1002/gcc.21984
Boyd LK, Mao X, Lu Y-J(2012). The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol vol. 9, (11) 652-664.
10.1038/nrurol.2012.185
Boyd LK, Mao X, Xue L, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Yu Y et al.(2012). High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes Cancer vol. 51, (6) 579-589.
10.1002/gcc.21944
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Chaplin T, Xue L, Xu M et al.(2012). Identification of ZDHHC14 as a novel tumor suppressor gene commonly downregulated in human cancers. CANCER RESEARCH vol. 72,
10.1158/1538-7445.AM2012-4858
Mao X, Coll Bastus N, Boyd L, Yu Y, Ren G, Beltran L, Oliver R, Young BD et al.(2012). The different genetic alterations between Western and Chinese prostate cancers and the underlying mechanisms. J Clin Oncol vol. 30, (5_suppl)
Lu Y-J, Liu X, Mao X, Hylands L, Clark J, Cooper C, Ren G(2012). Truncation of BRAF and Raf1 in prostate cancer in China. JOURNAL OF CLINICAL ONCOLOGY vol. 30, (5)
10.1200/jco.2012.30.5_suppl.77
Lu YJ, Liu X, Mao X, Hylands L, Clark J, Cooper C, Ren G(2012). Truncation of BRAF and Raf1 in prostate cancer in China. J Clin Oncol vol. 30, (5_suppl)
Xue L, Mao X, Ren G, Stankiewicz E, Kudahetti SC, Lin D, Beltran L, Berney DM et al.(2012). Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status. Am J Cancer Res vol. 2, (6) 736-744.
Ren G, Liu X, Mao X, Zhang Y, Stankiewicz E, Hylands L, Song R, Berney DM et al.(2012). Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancer. Genes Chromosomes and Cancer
10.1002/gcc.21984
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E et al.(2011). Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. NAT GENET vol. 43, (8) 785-U96.
10.1038/ng.882
Lu YJ, Mao X, Yu Y, Boyd LK, Oliver RTD, Berney DM (2011). Distinct genomic differences in prostate cancer between western countries and china. BRITISH JOURNAL OF SURGERY. vol. 98, E3-E3.
Bastus NC, Lu Y-J, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, Oliver TD, Berney DM(2011). Enhanced androgen signalling pathway increases the risk of prostate cancer through induction of TMPRSS2:ERG fusion. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-3048
Allen M, Syed N, Luong F, Howarth K, Gorman P, Tomlinson I, Roylance R, Lu Y-J et al.(2011). Epigenetic silencing of argininosuccinate synthetase renders human bladder cancer cells sensitive to pegylated arginine deiminase. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-76
Boyd LK, Xue L, Mao X, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Bisson I et al.(2011). Monoclonal origin of multifocal cancer and the step-wise genetic events of prostate carcinogenesis. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-4831
Lu Y-J, Mao X, Xue L, Boyd LK, Kudahetti SC, Yu Y, Ren G, Lin D et al.(2011). The different genetic alterations between Western and Chinese samples indicate alternate pathways of prostate cancer development. CANCER RESEARCH vol. 71,
10.1158/1538-7445.AM2011-3878
Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, Lu Y-J, Watkin N et al.(2011). Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One vol. 6, (3)
10.1371/journal.pone.0017517
Stankiewicz E, Mesher D, Ng M, Cuzick J, Prowse D, Hiscock F, Lu YJ, Lam W et al. (2011). Alternative Pathways of Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas. MODERN PATHOLOGY. vol. 24, 225A-226A.
Vasiljevi¿ N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L et al.(2011). Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers vol. 30, (4) 151-161.
10.3233/DMA-2011-0790
Mao X, Boyd LK, Yáñez-Muñoz RJ, Chaplin T, Xue L, Lin D, Shan L, Berney DM et al.(2011). Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer. Am J Cancer Res vol. 1, (5) 604-617.
Bastus NC, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, Oliver RTD, Berney DM, Lu Y-J(2010). Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res vol. 70, (23) 9544-9548.
10.1158/0008-5472.CAN-10-1638
Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E et al.(2010). Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res vol. 70, (13) 5207-5212.
10.1158/0008-5472.CAN-09-4074
Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, Sharp S, Chaplin T et al.(2010). The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. Am J Pathol vol. 176, (6) 2607-2615.
10.2353/ajpath.2010.090780
Shan L, Ambroisine L, Clark J, Yáñez-Muñoz RJ, Fisher G, Kudahetti SC, Yang J, Kia S et al.(2010). The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer. Prostate Cancer Prostatic Dis vol. 13, (2) 117-125.
10.1038/pcan.2010.2
Pantazi E, Trigiante G, Warnes G, Gemenetzidis E, Teh MT, Ikram M, Shan L, Lu YJ et al. (2010). Overexpression of GLI2 in human keratinocytes results in resistance to ultraviolet B-induced apoptosis and increased chromosomal instability. BRITISH JOURNAL OF DERMATOLOGY. vol. 162, 948-948.
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL et al.(2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. NAT GENET vol. 41, (10) 1116-U97.
10.1038/ng.450
Perry J, Powles T, Shamash J, Veerupillai A, McGrowder E, Noel E, Lu Y-J, Oliver T et al.(2009). The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines. Cancer Chemother Pharmacol vol. 64, (5) 925-933.
10.1007/s00280-009-0944-6
Cai X, Xiao T, James SY, Da J, Lin D, Liu Y, Zheng Y, Zou S et al.(2009). Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2. Lung Cancer vol. 65, (3) 299-305.
10.1016/j.lungcan.2009.06.001
Boyd LK, Mao X, Lu YJ(2009). Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: Tools and prospects. Expert Opinion on Medical Diagnostics vol. 3, (3) 313-326.
10.1517/17530050902828325
Mao X, Young BD, Chaplin T, Shipley J, Lu Y-J(2008). Subtle genomic alterations and genomic instability revealed in diploid cancer cell lines. Cancer Lett vol. 267, (1) 49-54.
10.1016/j.canlet.2008.03.003
Noel EE, Perry J, Chaplin T, Mao X, Cazier J-B, Joel SP, Oliver RTD, Young BD et al.(2008). Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines. Genes Chromosomes Cancer vol. 47, (7) 604-613.
10.1002/gcc.20564
Mao X, Shaw G, James SY, Purkis P, Kudahetti SC, Tsigani T, Kia S, Young BD et al.(2008). Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells. Asian J Androl vol. 10, (3) 467-473.
10.1111/j.1745-7262.2008.00401.x
Lane T, Hines J, Strefford J, Lu YJ, Yanez-Munoz R, Oliver T(2008). The t(4;6) chromosomal translocation is a recurrent event in prostate cancer. EUR UROL SUPPL vol. 7, (3) 272-272.
10.1016/S1569-9056(08)60801-5
Noel EE, Ragavan N, Walsh MJ, James SY, Matanhelia SS, Nicholson CM, Lu Y-J, Martin FL(2008). Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland. Prostate Cancer Prostatic Dis vol. 11, (2) 173-180.
10.1038/sj.pcan.4500997
McIntyre A, Summersgill B, Lu YJ, Missiaglia E, Kitazawa S, Oosterhuis JW, Looijenga LH, Shipley J(2007). Genomic copy number and expression patterns in testicular germ cell tumours. BRIT J CANCER vol. 97, (12) 1707-1712.
10.1038/sj.bjc.6604079
Li NF, Broad S, Lu YJ, Yang JS, Watson R, Hagemann T, Wilbanks G, Jacobs I et al.(2007). Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif vol. 40, (5) 780-794.
10.1111/j.1365-2184.2007.00462.x
Mao X, James SY, Yáñez-Muñoz RJ, Chaplin T, Molloy G, Oliver RTD, Young BD, Lu Y-J(2007). Rapid high-resolution karyotyping with precise identification of chromosome breakpoints. Genes Chromosomes Cancer vol. 46, (7) 675-683.
10.1002/gcc.20452
Zhou YP, Ye HT, Martin-Subero JI, Gesk S, Hamoudi R, Lu YJ, Wang R, Shipley J et al.(2007). The pattern of genomic gains in salivary gland MALT lymphomas. HAEMATOL-HEMATOL J vol. 92, (7) 921-927.
10.3324/haematol.10191
Mao X, Young BD, Lu Y-J(2007). The application of single nucleotide polymorphism microarrays in cancer research. Curr Genomics vol. 8, (4) 219-228.
10.2174/138920207781386924
Lane TM, Strefford JC, Yáñez-Muñoz RJ, Purkis P, Forsythe E, Nia T, Hines J, Lu Y-J et al.(2007). Identification of a recurrent t(4;6) chromosomal translocation in prostate cancer. J Urol vol. 177, (5) 1907-1912.
10.1016/j.juro.2007.01.001
Williamson D, Selfe J, Gordon T, Lu YJ, Pritchard-Jones K, Murai K, Jones P, Workman P et al.(2007). Role for amplification and expression of Glypican-5 in rhabdomyosarcoma. CANCER RES vol. 67, (1) 57-65.
10.1158/0008-5472.CAN-06-1650
Williamson D, Lu YJ, Fang C, Pritchard-Jones K, Shipley J(2006). Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma. GENE CHROMOSOME CANC vol. 45, (9) 839-845.
10.1002/gcc.20347
Zhou YP, Ye HT, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R, Siebert R, Shipley J et al.(2006). Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). BRIT J HAEMATOL vol. 133, (1) 35-42.
10.1111/j.1365-2141.2006.05969.x
Kote-Jarai Z, Salmon A, Mengitsu T, Copeland M, Ardern-Jones A, Locke I, Shanley S, Summersgill B et al.(2006). Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. BRIT J CANCER vol. 94, (2) 308-310.
10.1038/sj.bjc.6602912
Strefford JC, Lane TM, Hill A, LeRoux L, Foot NJ, Shipley J, Oliver RTD, Lu Y-J et al.(2006). Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP. Cytogenet Genome Res vol. 112, (1-2) 45-52.
10.1159/000087512
Lu Y-J, Yang J, Noel E, Skoulakis S, Chaplin T, Raghavan M, Purkis T, McIntyre A et al.(2005). Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development. Cancer Res vol. 65, (20) 9137-9141.
10.1158/0008-5472.CAN-05-1697
Wilson C, Yang J, Strefford JC, Summersgill B, Young BD, Shipley J, Oliver T, Lu Y-J(2005). Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Genes Chromosomes Cancer vol. 43, (2) 211-216.
10.1002/gcc.20173
Strefford JC, Stasevich I, Lane TM, Lu Y-J, Oliver T, Young BD(2005). A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genet Cytogenet vol. 159, (1) 1-9.
10.1016/j.cancergencyto.2004.09.020
Williamson D, Lu YJ, Gordon T, Sciot R, Kelsey A, Fisher C, Poremba C, Anderson J et al.(2005). Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J CLIN ONCOL vol. 23, (4) 880-888.
10.1200/JCO.2005.11.078
Williamson D, Lu YJ, McIntyre A, Summersgill B, Wang RB, Selfe J, Cooper C, Clark J et al.(2004). Comparative genomic hybridisation and comparative expressed sequence hybridisation as complements to microarray analyses of tumours. MUTAGENESIS vol. 19, (6) 509-509.
Bader DL, WANG W, Lu Y, Li ZY, Parker KH(2004). Interaction between fluid and solid i extracellular matrix. Recent Advances in Fluid Mechanics679-682.
Lu YJ, Williamson D, Wang R, Summersgill B, Rodriguez S, Rogers S, Pritchard-Jones K, Campbell C et al.(2003). Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior. GENE CHROMOSOME CANC vol. 38, (3) 207-214.
10.1002/gcc.10276
Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C, Shipley J(2003). Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. MODERN PATHOL vol. 16, (8) 778-785.
10.1097/01.MP.0000083648.45923.2B
Osin P, Lu YJ, Stone J, Crook T, Houlston RS, Gasco M, Gusterson BA, Shipley J(2003). Distinct genetic and epigenetic changes in medullary breast cancer. INT J SURG PATHOL vol. 11, (3) 153-158.
10.1177/106689690301100301
Rodriguez S, Jafer O, Goker H, Summersgill BM, Zafarana G, Gillis AJM, van Gurp RJHLM, Oosterhuis JW et al.(2003). Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. ONCOGENE vol. 22, (12) 1880-1891.
10.1038/sj.onc.1206302
Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA, Fisher C, Finlayson CJ et al.(2002). Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. BRIT J CANCER vol. 87, (4) 446-448.
10.1038/sj.bjc.6600502
Lu YJ, Hing S, Williams R, Pinkerton R, Shipley J, Pritchard-Jones K, UK Childrens Canc Study Grp(2002). Chromosome 1q expression profiling and relapse in Wilms' tumour. LANCET vol. 360, (9330) 385-386.
10.1016/S0140-6736(02)09596-X
Gao YN, Lu YJ, Xue SA, Chen HL, Wedderburn N, Griffin BE(2002). Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus. ONCOGENE vol. 21, (5) 825-835.
10.1038/sj.onc.1205130
Lu YJ, Williamson D, Clark J, Wang R, Tiffin N, Skelton L, Gordon T, Williams R et al.(2001). Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. P NATL ACAD SCI USA vol. 98, (16) 9197-9202.
10.1073/pnas.161272798
Summersgill B, Osin P, Lu YJ, Huddart R, Shipley J(2001). Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer vol. 85, (2) 213-220.
10.1054/bjoc.2001.1889
Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J(2001). Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. GENE CHROMOSOME CANC vol. 31, (1) 54-64.
10.1002/gcc.1118
Lu YJ, Condie A, Bennett JD, Fry MJ, Yuille MR, Shipley J(2001). Disruption of the ATM gene in breast cancer. CANCER GENET CYTOGEN vol. 126, (2) 97-101.
10.1016/S0165-4608(00)00401-5
Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M et al.(2001). Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol vol. 158, (2) 393-398.
10.1016/S0002-9440(10)63982-X
Cheng S, Gao Y, Dong X, Lu Y, An Q, Tong T, Wang Y(2001). Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung. Cancer Lett vol. 162 Suppl, S5-S10.
10.1016/S0304-3835(00)00641-8
Return to top